Search

Search bills, members, committees and pages...

Sign In

S. 4109

U.S. Senate•Senate Floor Calendar

Summary

S. 4109, the Stem Cell Therapeutic and Research Reauthorization Act of 2026, was introduced in the Senate on Mar 17, 2026 by Sen. Jack Reed (D) with 3 co-sponsors. It last saw action on Jun 22, 2026: Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.

Record

Text

S. 4109 has 3 co-sponsors.

sb4109/introduced-in-senate.txt
119 S4109 IS: Stem Cell Therapeutic and Research Reauthorization Act of 2026
 U.S. Senate
 2026-03-17
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 II  119th CONGRESS  2d Session  S. 4109  IN THE SENATE OF THE UNITED STATES   March 17, 2026   Mr. Reed  (for himself,  Mr. Scott of South Carolina ,  Ms. Smith , and  Mr. Lankford ) introduced the following bill; which was read twice and referred to the  Committee on Health, Education, Labor, and Pensions    A BILL
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.
1.
Short title
This Act may be cited as the   Stem Cell Therapeutic and Research Reauthorization Act of 2026  .
2.
Reauthorization of the C.W. Bill Young Cell Transplantation Program
Section 379B of the Public Health Service Act ( 42 U.S.C. 274m ) is amended—
(1)
by striking  appropriated $31,009,000  and inserting the following:
appropriated—
(1)
$31,009,000
 ;
(2)
in paragraph (1), as so inserted, by striking the period at the end and inserting  ; and ; and
(3)
by adding at the end the following:
(2)
$33,009,000 for each of fiscal years 2027 through 2031.
 .
3.
Cord blood inventory
Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 ( 42 U.S.C. 274k  note) is amended by striking  2026  and inserting  2031 .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

  1. Introduced2026-03-17
  2. Passed Senate
  3. Passed House
  4. Conference
  5. To President
  6. Became Law

CRS Summary

The summaries are the Congressional Research Service’s, one per stage. Read them in full.

Reported to Senate Jun 22, 2026

sb4109/reported-to-senate.md

Shown Here:
Reported to Senate (06/22/2026)

Stem Cell Therapeutic and Research Reauthorization Act of 2026

This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA).

The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. The bill also expands periodic reviews of the state of stem cell science to specifically include a review of the use of high-quality cord blood units and other emergent technologies to develop new therapies for potential inclusion in the program.

Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Sponsors

Sen. Jack Reed (D) sponsors S. 4109, and 3 members have co-sponsored it, all of them from the day it was introduced.

Committees

S. 4109 went before 1 committee: Health, Education, Labor, and Pensions.

Health, Education, Labor, and Pensions
Health, Education, Labor, and Pensions
Reported By · Jun 22, 2026 · 747 Bills

Actions

S. 4109 has taken 5 actions since Mar 17, 2026, the latest on Jun 22, 2026.

ChamberAction
Jun 22, 2026
Senate
Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.Health, Education, Labor, and Pensions Committee
Jun 22, 2026
Senate
Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
Jun 17, 2026
Senate
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.Health, Education, Labor, and Pensions Committee
Mar 17, 2026
Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1093)Health, Education, Labor, and Pensions Committee
Mar 17, 2026
—
Introduced in Senate

Votes

S. 4109 has not gone to a roll call.

1 bill is related to S. 4109.

Titles

S. 4109 goes by 4 titles, 2 of them short titles.

  • Stem Cell Therapeutic and Research Reauthorization Act of 2026 — Short Title(s) as Reported to Senate
  • Stem Cell Therapeutic and Research Reauthorization Act of 2026 — Display Title
  • Stem Cell Therapeutic and Research Reauthorization Act of 2026 — Short Title(s) as Introduced
  • A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. — Official Title as Introduced

Lobbying

7 clients hired 6 firms and 26 registered lobbyists who named S. 4109 in 11 quarterly filings, 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Health Issues, Budget/Appropriations, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Defense, Aviation/Airlines/Airports, Education, Homeland Security.

Clients

Who paid to be heard, by how many filings named the bill.

ClientBusinessStateFirmsFilingsReported
NMDPNonprofit organization that operates Be The Match RegistryMinnesota12$220K
ASTCTHealthcare SocietyDistrict of Columbia12$140K
COLLEGE OF AMERICAN PATHOLOGISTS—District of Columbia12—
NATIONAL MARROW DONOR PROGRAM—Minnesota12—
MEDICAL COLLEGE OF WISCONSINMedical CollegeWisconsin11$50K
AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO—Maryland11—
SUSAN B ANTHONY LIST—Virginia11—

Firms

Registrants who filed on the bill, by filings.

RegistrantClientsFilingsReported
VAN SCOYOC ASSOCIATES23$270K
COLLEGE OF AMERICAN PATHOLOGISTS12—
NATIONAL MARROW DONOR PROGRAM12—
SMITHBUCKLIN CORPORATION12$140K
AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES11—
SUSAN B ANTHONY LIST11—

Lobbyists

Named on the filings that cite the bill. The 20 named most often, of 26.

LobbyistFirmsClientsFilings
CHAD SCHULKEN123
ANNE SIMAYTIS112
DARREN FENWICK112
HARRY GLENN112
JENNIFER LATOURETTE112
JESSICA KNUTSON112
JUSTIN FISHER112
KRISTIN MCDONALD112
MATT HENKEN112
MICHAEL GIULIANI112
MICHAEL HURLBUT112
MOLLY FORD112
WILL SMITH112
AUTUMN CHRISTENSEN111
BILLY VALENTINE111
GWEN ANDERSON111
GWEN CHARLES111
JAMIE DANGERS111
JEREMY PILZ111
LAURIE KATZ111

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

ClientRegistrantPeriodReportedDocument
SUSAN B ANTHONY LISTSUSAN B ANTHONY LIST2026 second_quarter$420K2nd Quarter - Report
NATIONAL MARROW DONOR PROGRAMNATIONAL MARROW DONOR PROGRAM2026 first_quarter$320K1st Quarter - Report
COLLEGE OF AMERICAN PATHOLOGISTSCOLLEGE OF AMERICAN PATHOLOGISTS2026 first_quarter$305.9K1st Quarter - Report
NATIONAL MARROW DONOR PROGRAMNATIONAL MARROW DONOR PROGRAM2026 second_quarter$300K2nd Quarter - Report
COLLEGE OF AMERICAN PATHOLOGISTSCOLLEGE OF AMERICAN PATHOLOGISTS2026 second_quarter$180.1K2nd Quarter - Report
NMDPVAN SCOYOC ASSOCIATES2026 second_quarter$110K2nd Quarter - Report
NMDPVAN SCOYOC ASSOCIATES2026 first_quarter$110K1st Quarter - Report
ASTCTSMITHBUCKLIN CORPORATION2026 second_quarter$70K2nd Quarter - Report
ASTCTSMITHBUCKLIN CORPORATION2026 first_quarter$70K1st Quarter - Report
MEDICAL COLLEGE OF WISCONSINVAN SCOYOC ASSOCIATES2026 second_quarter$50K2nd Quarter - Report
AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOAMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES2026 first_quarter—1st Quarter - Report

Classification

The Congressional Research Service files S. 4109 under Health, one of its 31 policy areas, and gives it 5 legislative subjects.

CRS Subjects

CRS assigns every bill one policy area from its 31; S. 4109’s is Health.

s4109/policy-areas.txt
HealthAgriculture and FoodAnimalsArmed Forces and National SecurityArts, Culture, ReligionCivil Rights and Liberties, Minority IssuesCommerceCongressCrime and Law EnforcementEconomics and Public FinanceEducationEmergency ManagementEnergyEnvironmental ProtectionFamiliesFinance and Financial SectorForeign Trade and International FinanceGovernment Operations and PoliticsHousing and Community DevelopmentImmigrationInternational AffairsLabor and EmploymentLawNative AmericansPublic Lands and Natural ResourcesScience, Technology, CommunicationsSocial WelfareSports and RecreationTaxationTransportation and Public WorksWater Resources Development

Legislative Subjects

S. 4109 carries 5 of CRS’s legislative subjects, from Biological and life sciences to Organ and tissue donation and transplantation.

s4109/subjects.txt
Biological and life sciencesBlood and blood diseasesCell biology and embryologyHealth programs administration and fundingOrgan and tissue donation and transplantation

Source: congress.gov · legiscan.com